• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    More On SLNCF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Silence Therapeutics plc (SLNCF)

    -Other OTC
    3.09 0.00(0.00%) Dec 17, 3:54PM EST
    Add to Portfolio
    Prev Close:3.09
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:3.09 - 3.09
    52wk Range:2.80 - 6.35
    Volume:0
    Avg Vol (3m):216
    Market Cap:150.67M
    P/E (ttm):N/A
    EPS (ttm):-0.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ยป More Headlines for SLNCF

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,157.60
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Silence Therapeutics plc, a biotechnology company, discovers, develops, and delivers RNA interference (RNAi) therapeutics for the treatment of serious diseases primarily in North America and the Asia/Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback